Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,481 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Completed

ATHN 11: Liver Transplantation Outcomes Study

NCT04055051

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Orthopaedic Institute for Children Hemophilia Program Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Indiana Hemophilia and Thrombosis Center (IHTC) Indianapolis, Indiana, United States
View all 15 locations
View Trial Details
Completed

Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine Consultation

NCT05699980

Conditions
Blood Coagulation Disorders, Dermatoporosis, Hematologic Diseases, +7 more
Locations
  • Stéphanie Chevalier Ancerville, France
  • Wissam Al Shouaib Basse-Ham, France
  • Sophie LARUELLE Bénaménil, France
  • Sophie Delaporte Bulgnéville, France
View all 15 locations
View Trial Details
Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

NCT05804734

Conditions
Anticoagulant-induced Bleeding, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • Hemophilia treatment center of Brest Brest, France
  • Hemophilia treatment center of caen Caen, France
  • Hemophilia treatment center of Le Mans Le Mans, France
  • Hemophilia treatment center of Nantes Nantes, France
View Trial Details
Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site Boston, Massachusetts, United States
View all 101 locations
View Trial Details
Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT01151423

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator Site Los Angeles, California, United States
  • Investigator Site Washington D.C., District of Columbia, United States
  • Investigator Site Atlanta, Georgia, United States
  • Investigator Site St Louis, Missouri, United States
View all 51 locations
View Trial Details

Related conditions